Schubert E L, Hansen M F, Strong L C
Department of Molecular Genetics, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Ann Med. 1994 Jun;26(3):177-84. doi: 10.3109/07853899409147887.
The first human tumour suppressor gene, the Retinoblastoma Susceptibility gene (RB1) was first demonstrated in retinoblastoma, a rare paediatric eye tumour which has been studied extensively over the last century. Genetic studies of retinoblastoma have yielded unique insights into familial cancer syndromes and the mechanisms of oncogenesis by tumour suppressor genes such as the RB1 gene. In this view, we will summarize past research into the genetics of retinoblastoma that led to the discovery of the RB1 gene and discuss the influence these results have had on the field of cancer research. In addition, we will discuss current research into RB1 as it relates to cancer and its potential for new therapies.
首个人类肿瘤抑制基因——视网膜母细胞瘤易感基因(RB1)最初是在视网膜母细胞瘤中被发现的,视网膜母细胞瘤是一种罕见的儿童眼部肿瘤,在上个世纪得到了广泛研究。视网膜母细胞瘤的遗传学研究为家族性癌症综合征以及诸如RB1基因等肿瘤抑制基因的肿瘤发生机制提供了独特的见解。基于此观点,我们将总结过去对视网膜母细胞瘤遗传学的研究,这些研究促成了RB1基因的发现,并讨论这些结果对癌症研究领域产生的影响。此外,我们还将讨论目前与癌症相关的RB1研究及其在新疗法方面的潜力。